Arena Pharmaceuticals Inc Net debt/EBITDA
Mi az Arena Pharmaceuticals Inc Net debt/EBITDA?
A Net debt/EBITDA az Arena Pharmaceuticals Inc - 5.86
Mi a Net debt/EBITDA meghatározása?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA a Health Care szektor a NASDAQ-on cégekben a Arena Pharmaceuticals Inc -hoz képest
Mit csinál Arena Pharmaceuticals Inc?
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
net debt/ebitda -hoz hasonló cégek Arena Pharmaceuticals Inc
- ImpediMed nak Net debt/EBITDA 5.84 van
- TMAC Resources nak Net debt/EBITDA 5.85 van
- Virtusa Corp nak Net debt/EBITDA 5.85 van
- Atlas Engineered Products nak Net debt/EBITDA 5.85 van
- Mettler-Toledo International nak Net debt/EBITDA 5.85 van
- AstroNova Inc nak Net debt/EBITDA 5.85 van
- Arena Pharmaceuticals Inc nak Net debt/EBITDA 5.86 van
- Canada Nickel nak Net debt/EBITDA 5.86 van
- China SXT Pharmaceuticals Inc nak Net debt/EBITDA 5.86 van
- Rockwell Automation nak Net debt/EBITDA 5.86 van
- Rockwell Automation nak Net debt/EBITDA 5.86 van
- Meridian nak Net debt/EBITDA 5.87 van
- Coppercorp Resources Inc nak Net debt/EBITDA 5.87 van